CALLIE HART: Open Payments
NPI 1104458942 · MT PLEASANT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,592 in 182 payments from 25 companies in 2025. Trend: 2023 $1,272 · 2024 $2,822 · 2025 $3,592
Food & beverage: $3,530Education: $61
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $757 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 24 | $510 |
| Janssen Biotech, Inc. | 17 | $409 |
| Gilead Sciences, Inc. | 8 | $245 |
| Lilly USA, LLC | 9 | $181 |
| Celltrion USA Inc. | 18 | $176 |
| PFIZER INC. | 9 | $176 |
| Novo Nordisk Inc | 3 | $159 |
| Ardelyx, Inc. | 8 | $141 |
| QOL Medical, LLC | 5 | $122 |
Products named: XIFAXAN, TREMFYA, RINVOQ, CREON, OMVOH, VEGZELMA, LINZESS, Wegovy.
Industry payments across MI — which companies pay providers there.
